-
Je něco špatně v tomto záznamu ?
PAK1 and PAK2 in cell metabolism regulation
T. Kořánová, L. Dvořáček, D. Grebeňová, P. Röselová, A. Obr, K. Kuželová
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
34750857
DOI
10.1002/jcb.30175
Knihovny.cz E-zdroje
- MeSH
- HEK293 buňky MeSH
- HeLa buňky MeSH
- lidé MeSH
- mitochondrie enzymologie genetika MeSH
- nádorové mikroprostředí * MeSH
- nádorové proteiny genetika metabolismus MeSH
- nádory enzymologie genetika MeSH
- p21 aktivované kinasy genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
P21-activated kinases (PAKs) regulate processes associated with cytoskeletal rearrangements, such as cell division, adhesion, and migration. The possible regulatory role of PAKs in cell metabolism has not been well explored, but increasing evidence suggests that a cell metabolic phenotype is related to cell interactions with the microenvironment. We analyzed the impact of PAK inhibition by small molecule inhibitors, small interfering RNA, or gene knockout on the rates of mitochondrial respiration and aerobic glycolysis. Pharmacological inhibition of PAK group I by IPA-3 induced a strong decrease in metabolic rates in human adherent cancer cell lines, leukemia/lymphoma cell lines, and primary leukemia cells. The immediate effect of FRAX597, which inhibits PAK kinase activity, was moderate, indicating that PAK nonkinase functions are essential for cell metabolism. Selective downregulation or deletion of PAK2 was associated with a shift toward oxidative phosphorylation. In contrast, PAK1 knockout resulted in increased glycolysis. However, the overall metabolic capacity was not substantially reduced by PAK1 or PAK2 deletion, possibly due to partial redundancy in PAK1/PAK2 regulatory roles or to activation of other compensatory mechanisms.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011162
- 003
- CZ-PrNML
- 005
- 20220506130015.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jcb.30175 $2 doi
- 035 __
- $a (PubMed)34750857
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kořánová, Tereza $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 245 10
- $a PAK1 and PAK2 in cell metabolism regulation / $c T. Kořánová, L. Dvořáček, D. Grebeňová, P. Röselová, A. Obr, K. Kuželová
- 520 9_
- $a P21-activated kinases (PAKs) regulate processes associated with cytoskeletal rearrangements, such as cell division, adhesion, and migration. The possible regulatory role of PAKs in cell metabolism has not been well explored, but increasing evidence suggests that a cell metabolic phenotype is related to cell interactions with the microenvironment. We analyzed the impact of PAK inhibition by small molecule inhibitors, small interfering RNA, or gene knockout on the rates of mitochondrial respiration and aerobic glycolysis. Pharmacological inhibition of PAK group I by IPA-3 induced a strong decrease in metabolic rates in human adherent cancer cell lines, leukemia/lymphoma cell lines, and primary leukemia cells. The immediate effect of FRAX597, which inhibits PAK kinase activity, was moderate, indicating that PAK nonkinase functions are essential for cell metabolism. Selective downregulation or deletion of PAK2 was associated with a shift toward oxidative phosphorylation. In contrast, PAK1 knockout resulted in increased glycolysis. However, the overall metabolic capacity was not substantially reduced by PAK1 or PAK2 deletion, possibly due to partial redundancy in PAK1/PAK2 regulatory roles or to activation of other compensatory mechanisms.
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x enzymologie $x genetika $7 D008928
- 650 _2
- $a nádorové proteiny $x genetika $x metabolismus $7 D009363
- 650 _2
- $a nádory $x enzymologie $x genetika $7 D009369
- 650 12
- $a nádorové mikroprostředí $7 D059016
- 650 _2
- $a p21 aktivované kinasy $x genetika $x metabolismus $7 D054462
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dvořáček, Lukáš $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Grebeňová, Dana $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Röselová, Pavla $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Obr, Adam $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Kuželová, Kateřina $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000296286255 $7 xx0115456
- 773 0_
- $w MED00002577 $t Journal of cellular biochemistry $x 1097-4644 $g Roč. 123, č. 2 (2022), s. 375-389
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34750857 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130007 $b ABA008
- 999 __
- $a ok $b bmc $g 1788984 $s 1162360
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 123 $c 2 $d 375-389 $e 20211108 $i 1097-4644 $m Journal of cellular biochemistry $n J Cell Biochem $x MED00002577
- LZP __
- $a Pubmed-20220425